Published in J Pathol on April 01, 2003
SURF1, encoding a factor involved in the biogenesis of cytochrome c oxidase, is mutated in Leigh syndrome. Nat Genet (1998) 3.79
Fibroblast immortality is a prerequisite for transformation by EJ c-Ha-ras oncogene. Nature (1983) 2.77
Telomerase repressor sequences on chromosome 3 and induction of permanent growth arrest in human breast cancer cells. J Natl Cancer Inst (1999) 1.73
Mutagenicity of carcinogenic methylating agents is associated with a specific DNA modification. Nature (1980) 1.71
Telomere length abnormalities in mammalian radiosensitive cells. Cancer Res (2001) 1.54
Exceptional mutagenicity of a benzo(a)pyrene diol epoxide in cultured mammalian cells. Nature (1976) 1.40
Human acrocentric chromosomes with transcriptionally silent nucleolar organizer regions associate with nucleoli. EMBO J (2001) 1.35
Induction of immortality is an early event in malignant transformation of mammalian cells by carcinogens. Nature (1982) 1.26
A novel syndrome affecting multiple mitochondrial functions, located by microcell-mediated transfer to chromosome 2p14-2p13. Am J Hum Genet (2001) 1.22
Construction and characterization of a highly stable human: rodent monochromosomal hybrid panel for genetic complementation and genome mapping studies. Cytogenet Cell Genet (1995) 1.21
The mRNA expression of SETD2 in human breast cancer: correlation with clinico-pathological parameters. BMC Cancer (2009) 1.20
WNT5A expression in human breast cancer. Anticancer Res (2005) 1.18
Regulation of human telomerase activity: repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity. Cancer Res (2001) 1.18
hTERT mRNA expression correlates with telomerase activity in human breast cancer. Eur J Surg Oncol (2003) 1.13
hTERT expression in human breast cancer and non-cancerous breast tissue: correlation with tumour stage and c-Myc expression. Breast Cancer Res Treat (2003) 1.04
Evidence for the inactivation of multiple replicative lifespan genes in immortal human squamous cell carcinoma keratinocytes. Oncogene (1997) 1.02
Telomerase suppression by chromosome 6 in a human papillomavirus type 16-immortalized keratinocyte cell line and in a cervical cancer cell line. J Natl Cancer Inst (2001) 0.98
Mechanisms involved in the immortalization of mammalian cells by ionizing radiation and chemical carcinogens. Carcinogenesis (1995) 0.96
The association between telomerase, histopathological parameters, and KI-67 expression in breast cancer. Am J Surg (1999) 0.93
Telomerase activity and lymphovascular invasion in breast cancer. Eur J Surg Oncol (2000) 0.92
Telomerase activity in melanoma and non-melanoma skin cancer. Br J Cancer (1999) 0.87
Carcinogen-specific mutational and epigenetic alterations in INK4A, INK4B and p53 tumour-suppressor genes drive induced senescence bypass in normal diploid mammalian cells. Oncogene (2012) 0.87
Cell-mediated mutagenesis in cultured Chinese hamster cells by carcinogenic polycyclic hydrocarbons: nature and extent of the associated hydrocarbon-DNA reaction. Mutat Res (1977) 0.86
Telomere-dependent senescence. Nat Biotechnol (1999) 0.86
Benzo(a)pyrene metabolism and DNA adduct formation in serially cultivated strains of human epidermal keratinocytes. Int J Cancer (1980) 0.86
Evidence of a tumour suppressive function of E2F1 gene in human breast cancer. Anticancer Res (2008) 0.86
The cytotoxic, mutagenic and clastogenic effects of chromium-containing compounds on mammalian cells in culture. Mutat Res (1979) 0.85
Inhibition of metabolic cooperation between mammalian cells in culture by tumor promoters. Carcinogenesis (1981) 0.84
Identification of human tumour suppressor genes by monochromosome transfer: rapid growth-arrest response mapped to 9p21 is mediated solely by the cyclin-D-dependent kinase inhibitor gene, CDKN2A (p16INK4A). Carcinogenesis (1996) 0.84
hTERT mRNA expression is associated with a poor clinical outcome in human breast cancer. Anticancer Res (2007) 0.82
Evidence of a tumour suppressor function for DLEC1 in human breast cancer. Anticancer Res (2010) 0.81
A telomere-independent senescence mechanism is the sole barrier to Syrian hamster cell immortalization. Oncogene (1998) 0.81
Prognostic and therapeutic implications of mTORC1 and Rictor expression in human breast cancer. Oncol Rep (2013) 0.80
Genetic and functional analyses exclude mortality factor 4 (MORF4) as a keratinocyte senescence gene. Cancer Res (1999) 0.80
Functional evidence of novel tumor suppressor genes for cutaneous malignant melanoma. Cancer Res (1999) 0.80
Human chromosome 16 suppresses metastasis but not tumorigenesis in rat prostatic tumor cells. Cancer Res (1998) 0.80
Identification of tumor metastasis suppressor region on the short arm of human chromosome 20. Genes Chromosomes Cancer (2001) 0.80
Localization of a novel tumor metastasis suppressor region on the short arm of human chromosome 2. Genes Chromosomes Cancer (2000) 0.80
The effect of different TP53 mutations on the chromosomal stability of a human colonic adenoma derived cell line with endogenous wild type TP53 activity, before and after DNA damage. Genes Chromosomes Cancer (1997) 0.80
Telomerase activity and prognosis in breast cancer. Eur J Surg Oncol (1999) 0.79
Multistep malignant transformation of mammalian cells by carcinogens: induction of immortality as a key event. Carcinog Compr Surv (1985) 0.79
Telomerase activity in phyllodes tumours. Eur J Surg Oncol (1999) 0.79
Novel use of a selectable fusion gene as an "in-out" marker for studying genetic loss in mammalian cells. Mol Carcinog (1995) 0.79
HTERT mRNA expression correlates with matrix metalloproteinase-1 and vascular endothelial growth factor expression in human breast cancer: a correlative study using RT-PCR. Anticancer Res (2007) 0.78
Cell-mediated mutagenesis in cultured Chinese hamster cells by polycyclic hydrocarbons: mutagenicity and DNA reaction related to carcinogenicity in a series of compounds. Int J Cancer (1979) 0.78
Morphological transformation of immortalized hamster dermal fibroblasts following treatment with simple alkylating carcinogens. Carcinogenesis (1988) 0.78
A quantitative comparison of the mutagenicity of carcinogenic polycyclic hydrocarbon derivatives in cultured mammalian cells. Int J Cancer (1979) 0.78
hTERT protein expression is independent of clinicopathological parameters and c-Myc protein expression in human breast cancer. J Carcinog (2005) 0.78
Evidence for a tumour suppressive function of APRG1 in breast cancer. Breast Cancer Res Treat (2005) 0.77
BRCA1 germline mutations in Cypriot breast cancer patients from 26 families with family history. Anticancer Res (2002) 0.77
The genetic basis of human keratinocyte immortalisation in squamous cell carcinoma development: the role of telomerase reactivation. Eur J Cancer (1997) 0.77
hMSH6 deficiency and inactivation of the alphaE-catenin invasion-suppressor gene in HCT-8 colon cancer cells. Clin Exp Metastasis (1999) 0.77
Mutational effects of retrovirus insertion on the genome of V79 cells by an attenuated retrovirus vector: implications for gene therapy. Gene Ther (2003) 0.76
Comment on prognostic and therapeutic implications of mTORC2 and rictor expression in human breast cancer. Breast Cancer Res Treat (2012) 0.75
Nongenotoxic carcinogens: development of detection methods based on mechanisms: a European project. Mutat Res (1996) 0.75
Transformation by the p21ras protein. Nature (1984) 0.75
Malignant transformation of mammalian cells in culture: delineation of stages and role of cellular oncogene activation. IARC Sci Publ (1985) 0.75
Human chromosome 21 determines growth factor dependence in human/mouse B-cell hybridomas. Cancer Res (1998) 0.75
The defect in the AT-like hamster cell mutants is complemented by mouse chromosome 9 but not by any of the human chromosomes. Mutat Res (1996) 0.75
Biochemical and immunological characterisation of mutants induced in V79 Chinese hamster cells by a benzo[a]pyrene diolepoxide. Carcinogenesis (1982) 0.75
Human squamous cell carcinomas lose a mortality gene from chromosome 6q14.3 to q15. Oncogene (2003) 0.75
Telomerase activity in the human breast. Breast (1999) 0.75